Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.
2.

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.

Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA.

Clin Endocrinol (Oxf). 2004 Jun;60(6):671-5.

PMID:
15163328
3.

Carbimazole induced ANCA positive vasculitis.

Pandey S, Kushwaha RS, Mehndiratta P, Mehndiratta MM.

J Assoc Physicians India. 2008 Oct;56:801-3. Erratum in: J Assoc Physicians India. 2008 Nov;56:903. Mehndiratta, M M [added].

PMID:
19263707
4.

Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease.

Marazuela M, Sánchez de Paco G, Jiménez I, Carraro R, Fernández-Herrera J, Pajares JM, Gómez-Pan A.

Endocr J. 2002 Jun;49(3):315-8.

5.

Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach.

Sève P, Stankovic K, Michalet V, Vial T, Scoazec JY, Broussolle C.

J Intern Med. 2005 Aug;258(2):191-5.

6.

Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.

McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A.

N Engl J Med. 1996 Jan 25;334(4):220-4.

7.

A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.

Grebe SK, Feek CM, Ford HC, Fagerström JN, Cordwell DP, Delahunt JW, Toomath RJ.

Clin Endocrinol (Oxf). 1998 May;48(5):585-92.

PMID:
9666870
8.

Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.

Bowman P, Osborne NJ, Sturley R, Vaidya B.

QJM. 2012 Feb;105(2):189-93. doi: 10.1093/qjmed/hcq248.

PMID:
21258054
9.

Graves' orbitopathy precipitated by iatrogenic hypothyroidism secondary to carbimazole for Graves' disease.

Dutta D, Kumar M, Mukhopadhyay S, Chowdhury S.

Indian J Pediatr. 2014 Nov;81(11):1244-5. doi: 10.1007/s12098-014-1443-2. No abstract available.

PMID:
24777624
10.

Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia.

Rahman MA, Birrell G, Stewart H, Lucraft H, Cheetham TD.

Arch Dis Child. 2003 Feb;88(2):158-9.

11.

Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review.

Mavrakanas TA, Bouatou Y, Samer C, de Seigneux S, Meyer P.

Ren Fail. 2013;35(3):414-7. doi: 10.3109/0886022X.2012.760356. Review.

PMID:
23343442
12.
13.

High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.

Dalan R, Leow MK, Ng DC.

Ann Clin Biochem. 2008 Nov;45(Pt 6):612-5. doi: 10.1258/acb.2008.008098.

PMID:
18941129
14.

[Carbimazole can be the cause of iron deficiency anemia?].

El Khattabi A, Sekkach Y, Seddik H, Zahid H.

Ann Pharm Fr. 2011 Nov;69(6):302-5. doi: 10.1016/j.pharma.2011.09.003. French.

PMID:
22115133
15.

Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.

El Refaei SM, Shawkat W.

Nucl Med Commun. 2008 Jul;29(7):642-8. doi: 10.1097/MNM.0b013e3282fda205.

PMID:
18528187
17.

[Hypersensitivity syndrome : a rare but severe adverse effect of antithyroid drugs].

Vinzio S, Goichot B, Andrès E, Schlienger JL.

Ann Endocrinol (Paris). 2000 May;61(2):151-3. French.

PMID:
10891666
18.

[A serious adverse effect: sepsis due to carbimazole].

Guardiola PD, Tenreiro AP.

Endocrinol Nutr. 2009 Aug-Sep;56(7):378-80. doi: 10.1016/S1575-0922(09)72457-X. Spanish.

PMID:
19883898
19.

Fatality complicating agranulocytosis in the setting of carbimazole therapy.

Lynch MJ, Woodford NW.

Forensic Sci Med Pathol. 2008;4(4):246-9. doi: 10.1007/s12024-008-9038-8.

PMID:
19291446
20.

Insulin autoantibodies before and after carbimazole therapy in Asian Indian patients with Graves' disease.

Goswami R, Jayasuryan N, Jaleel A, Tandon N, Kochupillai N.

Diabetes Res Clin Pract. 1998 Jun;40(3):201-6.

PMID:
9716924

Supplemental Content

Support Center